NYSE:COO - Cooper Companies Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $279.07 +3.06 (+1.11 %) (As of 02/15/2019 04:00 PM ET)Previous Close$276.01Today's Range$274.77 - $278.6352-Week Range$216.47 - $288.51Volume724,599 shsAverage Volume352,269 shsMarket Capitalization$13.77 billionP/E Ratio24.27Dividend Yield0.02%Beta0.88 ProfileDiscussionAnalyst RatingsChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email The Cooper Companies, Inc. operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia. It also provides range of products and services focusing on women, babies, and families, including medical devices, fertility, genomics, and diagnostics and contraception for hospitals and surgical centers, obstetricians' and gynecologists' (ob/gyns) medical offices, and fertility clinics. In addition, the company offers carrier preimplantation genetic screening, preimplantation genetic diagnosis, and screening used in IVF process; micro pipettes; IVF medical devices and systems; and PARAGARD, a contraceptive option. It markets its products under Biofinity, clarity 1day, MyDay, and Proclear 1 Day brand name through a network of field sales representatives, independent agents, and distributors. The Cooper Companies, Inc. was founded in 1980 and is headquartered in Pleasanton, California. Receive COO News and Ratings via Email Sign-up to receive the latest news and ratings for COO and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Ophthalmic goods Sub-IndustryHealth Care Supplies SectorMedical Current SymbolNYSE:COO Previous Symbol CUSIP21664840 Webwww.coopercos.com Phone925-460-3600Debt Debt-to-Equity Ratio0.60 Current Ratio2.03 Quick Ratio1.16Price-To-Earnings Trailing P/E Ratio24.27 Forward P/E Ratio24.18 P/E Growth2.19 Sales & Book Value Annual Sales$2.53 billion Price / Sales5.44 Cash Flow$17.3013 per share Price / Cash Flow16.13 Book Value$67.31 per share Price / Book4.15Profitability EPS (Most Recent Fiscal Year)$11.50 Net Income$139.90 million Net Margins5.52% Return on Equity17.70% Return on Assets9.10%Miscellaneous Employees12,000 Outstanding Shares49,339,000Market Cap$13.77 billion OptionableOptionable Cooper Companies (NYSE:COO) Frequently Asked Questions What is Cooper Companies' stock symbol? Cooper Companies trades on the New York Stock Exchange (NYSE) under the ticker symbol "COO." How often does Cooper Companies pay dividends? What is the dividend yield for Cooper Companies? Cooper Companies declared a semiannual dividend on Tuesday, January 8th. Stockholders of record on Tuesday, January 22nd will be given a dividend of $0.03 per share on Friday, February 8th. This represents a dividend yield of 0.02%. The ex-dividend date is Friday, January 18th. View Cooper Companies' Dividend History. How will Cooper Companies' stock buyback program work? Cooper Companies announced that its Board of Directors has initiated a share repurchase program on Friday, April 7th 2017, which permits the company to buyback $500,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to buy up to 5.2% of its stock through open market purchases. Stock buyback programs are typically a sign that the company's leadership believes its shares are undervalued. How were Cooper Companies' earnings last quarter? Cooper Companies Inc (NYSE:COO) issued its earnings results on Thursday, December, 6th. The medical device company reported $2.87 earnings per share for the quarter, missing analysts' consensus estimates of $2.96 by $0.09. The medical device company had revenue of $651.50 million for the quarter, compared to analyst estimates of $645.25 million. Cooper Companies had a net margin of 5.52% and a return on equity of 17.70%. The firm's revenue was up 16.0% compared to the same quarter last year. During the same period last year, the firm posted $2.65 earnings per share. View Cooper Companies' Earnings History. When is Cooper Companies' next earnings date? Cooper Companies is scheduled to release their next quarterly earnings announcement on Tuesday, March 5th 2019. View Earnings Estimates for Cooper Companies. How can I listen to Cooper Companies' earnings call? Cooper Companies will be holding an earnings conference call on Tuesday, March 5th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 8556434430. What guidance has Cooper Companies issued on next quarter's earnings? Cooper Companies issued an update on its FY19 earnings guidance on Thursday, December, 6th. The company provided earnings per share (EPS) guidance of $11.30-11.70 for the period, compared to the Thomson Reuters consensus estimate of $12.08. The company issued revenue guidance of $2.60-2.66 billion, compared to the consensus revenue estimate of $2.67 billion.Cooper Companies also updated its FY 2019 guidance to $11.30-11.70 EPS. What price target have analysts set for COO? 9 Wall Street analysts have issued twelve-month price objectives for Cooper Companies' shares. Their predictions range from $221.00 to $306.00. On average, they anticipate Cooper Companies' stock price to reach $290.00 in the next twelve months. This suggests a possible upside of 3.9% from the stock's current price. View Analyst Price Targets for Cooper Companies. What is the consensus analysts' recommendation for Cooper Companies? 9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cooper Companies in the last year. There are currently 1 sell rating, 1 hold rating and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Cooper Companies. Has Cooper Companies been receiving favorable news coverage? News articles about COO stock have trended neutral on Friday, InfoTrie reports. The research group identifies negative and positive press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Cooper Companies earned a coverage optimism score of 0.3 on InfoTrie's scale. They also gave news headlines about the medical device company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the stock's share price in the next few days. Who are some of Cooper Companies' key competitors? Some companies that are related to Cooper Companies include Shire (SHPG), Express Scripts (ESRX), HCA Healthcare (HCA), Vertex Pharmaceuticals (VRTX), Allergan (AGN), Zoetis (ZTS), Regeneron Pharmaceuticals (REGN), Illumina (ILMN), Shire (SHP), Humana (HUM), Baxter International (BAX), Edwards Lifesciences (EW), Takeda Pharmaceutical (TKPYY), Actelion (ALIOF) and FRESENIUS SE &/S (FSNUY). Who are Cooper Companies' key executives? Cooper Companies' management team includes the folowing people: Mr. Albert G. White III, Pres, CEO & Director (Age 49)Mr. Daniel G. McBride Esq., Chief Operating Officer, Exec. VP and Pres of CooperVision Inc (Age 55)Mr. Agostino Ricupati, Sr. VP of Fin. & Tax and Chief Accounting OfficerMr. Brian Andrews, Sr. VP, CFO & TreasurerMr. Kim Duncan, VP of Investor Relations & Admin. Who are Cooper Companies' major shareholders? Cooper Companies' stock is owned by many different of retail and institutional investors. Top institutional investors include BlackRock Inc. (7.57%), Massachusetts Financial Services Co. MA (5.46%), Frontier Capital Management Co. LLC (1.59%), Amundi Pioneer Asset Management Inc. (1.56%), Findlay Park Partners LLP (1.50%) and Geode Capital Management LLC (1.46%). Company insiders that own Cooper Companies stock include A Thomas Bender, Agostino Ricupati, Allan E Rubenstein, Carol R Kaufman, Daniel G Mcbride, Gary S Petersmeyer, Jody S Lindell, Michael Kalkstein, Paul L Remmell, Randal Golden, Robert S Weiss and Stanley Md Zinberg. View Institutional Ownership Trends for Cooper Companies. Which institutional investors are selling Cooper Companies stock? COO stock was sold by a variety of institutional investors in the last quarter, including Bessemer Group Inc., Amundi Pioneer Asset Management Inc., Frontier Capital Management Co. LLC, Los Angeles Capital Management & Equity Research Inc., Lord Abbett & CO. LLC, Massachusetts Financial Services Co. MA, Westfield Capital Management Co. LP and ClariVest Asset Management LLC. Company insiders that have sold Cooper Companies company stock in the last year include A Thomas Bender, Agostino Ricupati, Allan E Rubenstein, Carol R Kaufman, Daniel G Mcbride, Gary S Petersmeyer, Michael Kalkstein, Randal Golden, Robert S Weiss and Stanley Md Zinberg. View Insider Buying and Selling for Cooper Companies. Which institutional investors are buying Cooper Companies stock? COO stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Public Employees Retirement Association of Colorado, Atlanta Capital Management Co. L L C, California Public Employees Retirement System, First Trust Advisors LP, Geode Capital Management LLC, RWC Asset Management LLP and RWC Asset Management LLP. View Insider Buying and Selling for Cooper Companies. How do I buy shares of Cooper Companies? Shares of COO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Cooper Companies' stock price today? One share of COO stock can currently be purchased for approximately $279.07. How big of a company is Cooper Companies? Cooper Companies has a market capitalization of $13.77 billion and generates $2.53 billion in revenue each year. The medical device company earns $139.90 million in net income (profit) each year or $11.50 on an earnings per share basis. Cooper Companies employs 12,000 workers across the globe. What is Cooper Companies' official website? The official website for Cooper Companies is http://www.coopercos.com. How can I contact Cooper Companies? Cooper Companies' mailing address is 6140 Stoneridge Mall Road Suite 590, PLEASANTON CA, 94588. The medical device company can be reached via phone at 925-460-3600 or via email at [email protected] MarketBeat Community Rating for Cooper Companies (NYSE COO)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 437 (Vote Outperform)Underperform Votes: 392 (Vote Underperform)Total Votes: 829MarketBeat's community ratings are surveys of what our community members think about Cooper Companies and other stocks. Vote "Outperform" if you believe COO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe COO will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/15/2019 by MarketBeat.com StaffFeatured Article: How is a Moving Average Calculated?